Soumit Roy – JonesTrading Overall Analyst Ranking: Ranked #9,344 out of 9,358 Wall Street analysts, with a 18% success rate and an average return of -23.50% per rating.
He probably bailed on Anavex because he concluded that it wasn't going to be doing anything major for several years and found better uses for his time.
My guess is if there is an approval he will be back.
Thanks, but I'll bet he beats any other analyst following Avanex Life Sciences now....I've been away for more than 20 years and most of the people I worked with then have either retired or passed away....